CRISPR-Cas9 Mediated Epigenetic Reprogramming of Cardiac Fibroblasts as a Therapeutic Strategy for Post-Infarction Myocardial Remodeling. ISCSITR-IJMSRD. 2024;5(2):1-9. Accessed July 24, 2025. https://iscsitr.in/index.php/ISCSITR-IJMSRD/article/view/ISCSITR-IJMSRD_05_02_001